Bank of New York Mellon’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Buy
71,617
+2,185
+3% +$84.6K ﹤0.01% 2722
2026
Q1
$2.61M Buy
69,432
+2,177
+3% +$71.1K ﹤0.01% 2674
2025
Q4
$2.02M Buy
67,255
+23,536
+54% +$666K ﹤0.01% 2828
2025
Q3
$1.15M Buy
43,719
+14,701
+51% +$350K ﹤0.01% 3136
2025
Q2
$618K Buy
29,018
+7,822
+37% +$177K ﹤0.01% 3391
2025
Q1
$451K Buy
21,196
+7,597
+56% +$156K ﹤0.01% 3501
2024
Q4
$276K Buy
+13,599
New +$281K ﹤0.01% 3822

Other funds holding GRDN

Bank of New York Mellon's GRDN Position: Q2 2026 in Review

Bank of New York Mellon increased its Guardian Pharmacy Services (GRDN) stake by 3.1% in Q2 2026, buying an estimated $84.6K and bringing the position to 71,617 shares worth $3M. The position accounts for ﹤0.01% of the portfolio, ranked #2722.

Bank of New York Mellon first reported a position in GRDN in Q4 2024 and has held it in 7 quarters since. 80 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Bank of New York Mellon held 71,617 shares of Guardian Pharmacy Services worth $3M as of Q2 2026.
  • Bank of New York Mellon bought 2,185 Guardian Pharmacy Services shares in Q2 2026, an estimated $84.6K.
  • Guardian Pharmacy Services made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2722 holding.
  • Bank of New York Mellon first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 7 quarters since.
  • 80 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.